319 related articles for article (PubMed ID: 29096702)
1. Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells.
Wang L; Chen Y; Guan C; Zhao Z; Li Q; Yang J; Mo J; Wang B; Wu W; Yang X; Song L; Li J
Stem Cell Res Ther; 2017 Nov; 8(1):245. PubMed ID: 29096702
[TBL] [Abstract][Full Text] [Related]
2. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
3. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
6. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
7. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.
Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB
Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365
[TBL] [Abstract][Full Text] [Related]
9. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
[TBL] [Abstract][Full Text] [Related]
10. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
11. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
[TBL] [Abstract][Full Text] [Related]
12. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
13. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
[TBL] [Abstract][Full Text] [Related]
17. Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.
Brouwer M; Zhou H; Nadif Kasri N
Stem Cell Rev Rep; 2016 Feb; 12(1):54-72. PubMed ID: 26424535
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection.
Deng W; Cao X; Chen J; Zhang Z; Yu Q; Wang Y; Shao G; Zhou J; Gao X; Yu J; Xu X
ACS Appl Mater Interfaces; 2015 Sep; 7(34):18957-66. PubMed ID: 26269400
[TBL] [Abstract][Full Text] [Related]
19. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.
Wang AYL; Loh CYY
Cell Transplant; 2019 Dec; 28(1_suppl):112S-131S. PubMed ID: 31722555
[TBL] [Abstract][Full Text] [Related]
20. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]